Pritchard Michele T, McCracken Jennifer M
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66161, USA.
Curr Drug Targets. 2015;16(12):1332-46. doi: 10.2174/1389450116666150825111439.
The liver is unique in that it is able to regenerate. This regeneration occurs without formation of a scar in the case of non-iterative hepatic injury. However, when the liver is exposed to chronic liver injury, the purely regenerative process fails and excessive extracellular matrix proteins are deposited in place of normal liver parenchyma. While much has been discovered in the past three decades, insights into fibrotic mechanisms have not yet lead to effective therapies; liver transplant remains the only cure for advanced liver disease. In an effort to broaden the collection of possible therapeutic targets, this review will compare and contrast the liver wound healing response to that found in two types of wound healing: scarless wound healing of fetal skin and oral mucosa and scar-forming wound healing found in adult skin. This review will examine wound healing in the liver and the skin in relation to the role of humoral and cellular factors, as well as the extracellular matrix, in this process. While several therapeutic targets are similar between fibrotic liver and adult skin wound healing, others are unique and represent novel areas for hepatic anti-fibrotic research. In particular, investigations into the role of hyaluronan in liver fibrosis and fibrosis resolution are warranted.
肝脏的独特之处在于它具有再生能力。在非反复性肝损伤的情况下,这种再生过程不会形成瘢痕。然而,当肝脏受到慢性肝损伤时,单纯的再生过程会失败,过量的细胞外基质蛋白会沉积,取代正常的肝实质。尽管在过去三十年里已经有了很多发现,但对纤维化机制的深入了解尚未带来有效的治疗方法;肝移植仍然是晚期肝病的唯一治愈方法。为了扩大可能的治疗靶点范围,本综述将比较和对比肝脏伤口愈合反应与两种伤口愈合类型中的反应:胎儿皮肤和口腔黏膜的无瘢痕伤口愈合以及成人皮肤的瘢痕形成伤口愈合。本综述将研究肝脏和皮肤中的伤口愈合过程,涉及体液和细胞因子以及细胞外基质在此过程中的作用。虽然纤维化肝脏和成人皮肤伤口愈合之间有几个相似的治疗靶点,但其他靶点是独特的,代表了肝脏抗纤维化研究的新领域。特别是,有必要研究透明质酸在肝纤维化和纤维化消退中的作用。